These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

402 related items for PubMed ID: 23291968

  • 1. Glycodendrimers prevent HIV transmission via DC-SIGN on dendritic cells.
    Garcia-Vallejo JJ, Koning N, Ambrosini M, Kalay H, Vuist I, Sarrami-Forooshani R, Geijtenbeek TB, van Kooyk Y.
    Int Immunol; 2013 Apr; 25(4):221-33. PubMed ID: 23291968
    [Abstract] [Full Text] [Related]

  • 2. Lewis X component in human milk binds DC-SIGN and inhibits HIV-1 transfer to CD4+ T lymphocytes.
    Naarding MA, Ludwig IS, Groot F, Berkhout B, Geijtenbeek TB, Pollakis G, Paxton WA.
    J Clin Invest; 2005 Nov; 115(11):3256-64. PubMed ID: 16239964
    [Abstract] [Full Text] [Related]

  • 3. The dendritic cell-specific C-type lectin DC-SIGN is a receptor for Schistosoma mansoni egg antigens and recognizes the glycan antigen Lewis x.
    van Die I, van Vliet SJ, Nyame AK, Cummings RD, Bank CM, Appelmelk B, Geijtenbeek TB, van Kooyk Y.
    Glycobiology; 2003 Jun; 13(6):471-8. PubMed ID: 12626400
    [Abstract] [Full Text] [Related]

  • 4. DC-SIGN (dendritic cell-specific ICAM-grabbing non-integrin) and DC-SIGN-related (DC-SIGNR): friend or foe?
    Soilleux EJ.
    Clin Sci (Lond); 2003 Apr; 104(4):437-46. PubMed ID: 12653690
    [Abstract] [Full Text] [Related]

  • 5. Lentivirus-mediated RNA interference of DC-SIGN expression inhibits human immunodeficiency virus transmission from dendritic cells to T cells.
    Arrighi JF, Pion M, Wiznerowicz M, Geijtenbeek TB, Garcia E, Abraham S, Leuba F, Dutoit V, Ducrey-Rundquist O, van Kooyk Y, Trono D, Piguet V.
    J Virol; 2004 Oct; 78(20):10848-55. PubMed ID: 15452205
    [Abstract] [Full Text] [Related]

  • 6. Identification of the DC-SIGN-interactive domains on the envelope glycoprotein of HIV-1 CRF07_BC.
    Liao CF, Wang SF, Lin YT, Ho DD, Chen YM.
    AIDS Res Hum Retroviruses; 2011 Aug; 27(8):831-9. PubMed ID: 21142800
    [Abstract] [Full Text] [Related]

  • 7. Glycan-based DC-SIGN targeting vaccines to enhance antigen cross-presentation.
    van Kooyk Y, Unger WW, Fehres CM, Kalay H, García-Vallejo JJ.
    Mol Immunol; 2013 Sep; 55(2):143-5. PubMed ID: 23158834
    [Abstract] [Full Text] [Related]

  • 8. Potency of HIV-1 envelope glycoprotein gp120 antibodies to inhibit the interaction of DC-SIGN with HIV-1 gp120.
    Lekkerkerker AN, Ludwig IS, van Vliet SJ, van Kooyk Y, Geijtenbeek TB.
    Virology; 2004 Nov 24; 329(2):465-76. PubMed ID: 15518824
    [Abstract] [Full Text] [Related]

  • 9. Characterization of DC-SIGN/R interaction with human immunodeficiency virus type 1 gp120 and ICAM molecules favors the receptor's role as an antigen-capturing rather than an adhesion receptor.
    Snyder GA, Ford J, Torabi-Parizi P, Arthos JA, Schuck P, Colonna M, Sun PD.
    J Virol; 2005 Apr 24; 79(8):4589-98. PubMed ID: 15795245
    [Abstract] [Full Text] [Related]

  • 10. Dendritic cells recognize tumor-specific glycosylation of carcinoembryonic antigen on colorectal cancer cells through dendritic cell-specific intercellular adhesion molecule-3-grabbing nonintegrin.
    van Gisbergen KP, Aarnoudse CA, Meijer GA, Geijtenbeek TB, van Kooyk Y.
    Cancer Res; 2005 Jul 01; 65(13):5935-44. PubMed ID: 15994972
    [Abstract] [Full Text] [Related]

  • 11. DC-SIGN: escape mechanism for pathogens.
    van Kooyk Y, Geijtenbeek TB.
    Nat Rev Immunol; 2003 Sep 01; 3(9):697-709. PubMed ID: 12949494
    [Abstract] [Full Text] [Related]

  • 12. DCIR interacts with ligands from both endogenous and pathogenic origin.
    Bloem K, Vuist IM, van den Berk M, Klaver EJ, van Die I, Knippels LM, Garssen J, García-Vallejo JJ, van Vliet SJ, van Kooyk Y.
    Immunol Lett; 2014 Sep 01; 158(1-2):33-41. PubMed ID: 24239607
    [Abstract] [Full Text] [Related]

  • 13. Glycan-modified liposomes boost CD4+ and CD8+ T-cell responses by targeting DC-SIGN on dendritic cells.
    Unger WW, van Beelen AJ, Bruijns SC, Joshi M, Fehres CM, van Bloois L, Verstege MI, Ambrosini M, Kalay H, Nazmi K, Bolscher JG, Hooijberg E, de Gruijl TD, Storm G, van Kooyk Y.
    J Control Release; 2012 May 30; 160(1):88-95. PubMed ID: 22366522
    [Abstract] [Full Text] [Related]

  • 14. Lactoferrin prevents dendritic cell-mediated human immunodeficiency virus type 1 transmission by blocking the DC-SIGN--gp120 interaction.
    Groot F, Geijtenbeek TB, Sanders RW, Baldwin CE, Sanchez-Hernandez M, Floris R, van Kooyk Y, de Jong EC, Berkhout B.
    J Virol; 2005 Mar 30; 79(5):3009-15. PubMed ID: 15709021
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. DC-SIGN points the way to a novel mechanism for HIV-1 transmission.
    Masso M.
    MedGenMed; 2003 May 23; 5(2):2. PubMed ID: 14603101
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. DC-SIGN mediates adhesion and rolling of dendritic cells on primary human umbilical vein endothelial cells through LewisY antigen expressed on ICAM-2.
    García-Vallejo JJ, van Liempt E, da Costa Martins P, Beckers C, van het Hof B, Gringhuis SI, Zwaginga JJ, van Dijk W, Geijtenbeek TB, van Kooyk Y, van Die I.
    Mol Immunol; 2008 Apr 23; 45(8):2359-69. PubMed ID: 18155766
    [Abstract] [Full Text] [Related]

  • 20. C-type lectin Mermaid inhibits dendritic cell mediated HIV-1 transmission to CD4+ T cells.
    Nabatov AA, de Jong MA, de Witte L, Bulgheresi S, Geijtenbeek TB.
    Virology; 2008 Sep 01; 378(2):323-8. PubMed ID: 18597806
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.